Search research articles
Contact Us
Filters
Showing results (71-80 of 125) with videos related to
Page
of 13
Sort By:
Respiratory Medicine
|
October 2, 2007
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone
Jean Bousquet, Louis-Philippe Boulet, Matthew J Peters, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
December 1, 2005
Effect of beclomethasone dipropionate (BDP) as extrafine aerosol on bronchoalveolar lavage (BAL) lymphocytes in chronic sarcoidosis
Andrea Ludwig-Sengpiel, Elke Jaksztat, Lutz Welker, et al.
Respiration; International Review of Thoracic Diseases
|
November 14, 2017
Physical Activity and Fatigue in Patients with Sarcoidosis
Thomas Bahmer, Henrik Watz, Maria Develaska, et al.
The European Respiratory Journal
|
September 17, 2013
Prediction of new-onset asthma and nasal allergy by skin prick test and RAST in a cohort of adults
Kerstin Gallmeier, Eva Becker, Anne Kirsten, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
September 1, 2016
Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease
Roberto Rodriguez-Roisin, Kay Tetzlaff, Henrik Watz, et al.
Thorax
|
March 13, 2016
Reduced physical activity in lymphangioleiomyomatosis compared with COPD and healthy controls: disease-specific impact and clinical correlates
Thomas Bahmer, Henrik Watz, Benjamin Waschki, et al.
BMC Pulmonary Medicine
|
December 26, 2014
Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial
Kai M Beeh, Henrik Watz, Luis Puente-Maestu, et al.
Chest
|
September 10, 2011
Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD
Rainard Fuhr, Helgo Magnussen, Kristina Sarem, et al.
The European Respiratory Journal
|
January 2, 2013
The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers
Anne Kirsten, Henrik Watz, Frauke Pedersen, et al.
Respiratory Medicine
|
July 30, 2008
Development and validation of a cough and sputum assessment questionnaire
Bruce Crawford, Brigitta Monz, Jens Hohlfeld, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 125) with videos related to
Sort By:
Page
of 13
Respiratory Medicine
|
October 2, 2007
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone
Jean Bousquet, Louis-Philippe Boulet, Matthew J Peters, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
December 1, 2005
Effect of beclomethasone dipropionate (BDP) as extrafine aerosol on bronchoalveolar lavage (BAL) lymphocytes in chronic sarcoidosis
Andrea Ludwig-Sengpiel, Elke Jaksztat, Lutz Welker, et al.
Respiration; International Review of Thoracic Diseases
|
November 14, 2017
Physical Activity and Fatigue in Patients with Sarcoidosis
Thomas Bahmer, Henrik Watz, Maria Develaska, et al.
The European Respiratory Journal
|
September 17, 2013
Prediction of new-onset asthma and nasal allergy by skin prick test and RAST in a cohort of adults
Kerstin Gallmeier, Eva Becker, Anne Kirsten, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
September 1, 2016
Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease
Roberto Rodriguez-Roisin, Kay Tetzlaff, Henrik Watz, et al.
Thorax
|
March 13, 2016
Reduced physical activity in lymphangioleiomyomatosis compared with COPD and healthy controls: disease-specific impact and clinical correlates
Thomas Bahmer, Henrik Watz, Benjamin Waschki, et al.
BMC Pulmonary Medicine
|
December 26, 2014
Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial
Kai M Beeh, Henrik Watz, Luis Puente-Maestu, et al.
Chest
|
September 10, 2011
Efficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD
Rainard Fuhr, Helgo Magnussen, Kristina Sarem, et al.
The European Respiratory Journal
|
January 2, 2013
The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers
Anne Kirsten, Henrik Watz, Frauke Pedersen, et al.
Respiratory Medicine
|
July 30, 2008
Development and validation of a cough and sputum assessment questionnaire
Bruce Crawford, Brigitta Monz, Jens Hohlfeld, et al.
Page
of 13